𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Multimodality therapy of stage III adenocarcinoma of the breast

✍ Scribed by J. D. Bitran; R. K. Desser; D. Schifeling; C. M. Shapiro; M. F. Kozloff; E. Robin; W. Recant; A. Michel; H. Rochman; A. A. Billings

Publisher
John Wiley and Sons
Year
1983
Tongue
English
Weight
293 KB
Volume
22
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

✦ Synopsis

The results of a pilot multimodality program (surgery + radiotherapy + chemotherapy) are reported in 34 women with advanced stage I11 and IV adenocarcinoma of the breast. The median relapse-free survival for all patients was 24 months, with 74 % of the premenopausal patients and 37 % of the postmenopausal alive at five years (P=O. 18). The relapse rate was significantly lower in premenopausal patients when compared to the postmenopausal subgroup. Estrogen receptor status was not predictive for relapse or survival.

πŸ“œ SIMILAR VOLUMES

Multimodality treatment of noninflammato
Multimodality treatment of noninflammatory stage IIIb breast cancer
✍ GliΕ„ski, Bogdan; Pawlicki, Marek; Reinfuss, Marian; Skolyszewski, Jan; Brandys, πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 69 KB πŸ‘ 2 views

Background and Objectives: The 1990s have established the contribution of multimodality therapy in the management of IIIb noninflammatory breast cancer (IIIb NIBC), by reducing the odds of recurrence and death. Methods: A total of 300 women with IIIb NIBC received a multimodality therapy. The treatm